Page last updated: 2024-09-03
kn 04 and carbachol
kn 04 has been researched along with carbachol in 1 studies
Compound Research Comparison
Studies (kn 04) | Trials (kn 04) | Recent Studies (post-2010) (kn 04) | Studies (carbachol) | Trials (carbachol) | Recent Studies (post-2010) (carbachol) |
---|---|---|---|---|---|
12 | 0 | 0 | 13,918 | 81 | 968 |
Protein Interaction Comparison
Protein | Taxonomy | kn 04 (IC50) | carbachol (IC50) |
---|---|---|---|
Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.7849 | |
Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 2.0626 | |
Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 3.4134 | |
Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 2.9961 | |
Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 2.535 | |
Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 2.9961 | |
Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 2.6638 | |
Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 4.849 | |
Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 4.99 |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Fukunaga, K; Izumi, F; Kuroiwa, A; Minami, K; Miyamoto, E; Nakashima, Y; Tsutsui, M; Yanagihara, N | 1 |
Other Studies
1 other study(ies) available for kn 04 and carbachol
Article | Year |
---|---|
Ca(2+)/calmodulin-dependent protein kinase II inhibitor KN-62 inhibits adrenal medullary chromaffin cell functions independent of its action on the kinase.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adolescent; Adrenal Medulla; Animals; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Carbachol; Catecholamines; Cattle; Chromaffin System; Enzyme Inhibitors; Humans; Ion Channels; Isoquinolines; Nicotinic Agonists; Piperazines; Sodium; Tyrosine 3-Monooxygenase | 1996 |